1. Elizabeth C. Swanson, DO and Mark R. Schleiss M. Congenital cytomegalovirus infection: new prospects for prevention and therapy. Congenital cytomegalovirus infection: current strategies and future perspectives. Antiviral treatment of cytomegalovirus infection.//pediatr Clin North Al. 2013. Vol. 60, N 2. P. 1 - 17.

2. Lazzarotto T. et al. Congenital Cytomegalovirus Infection: A Narrative Review of the Issues in Screening and Management From a Panel of European Experts//Front. Pediatr. 2020. Vol. 8.

3. Davis N.L., King C.C., Kourtis A.P. Cytomegalovirus infection in pregnancy//Birth Defects Res. 2017. Vol. 109, N 5. P. 336 - 346.

4. Шахгильдян В.И. Диагностика и лечение цитомегаловирусной инфекции у беременных и новорожденных//Неонатология: новости, мнения, обучение. 2017. N 3. P. 70 - 82.

5. Emery V.C., Lazzarotto T. Cytomegalovirus in pregnancy and the neonate//F1000Res. 2017. Vol. 6. P. 138.

6. Picone O. et al. A series of 238 cytomegalovirus primary infections during pregnancy: Description and outcome//Prenat. Diagn. 2013. Vol. 33, N 8. P. 751 - 758.

7. Enders G. et al. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age//J. Clin. Virol. Elsevier B.V., 2011. Vol. 52, N 3. P. 244 - 246.

8. Simonazzi G. et al. Congenital Cytomegalovirus Infection: Prognostic Value of Maternal DNAemia at Amniocentesis//Clin Infect Dis. 2017. Vol. 64, N 2. P. 207 - 210.

9. Zavattoni M. et al. Monitoring of human cytomegalovirus DNAemia during primary infection in transmitter and non-transmitter mothers//J. Clin. Virol. Elsevier B.V., 2016. Vol. 82. P. 89 - 93.

10. Delforge M.L. et al. Presence of Cytomegalovirus in urine and blood of pregnant women with primary infection might be associated with fetal infection//J. Clin. Virol. 2017. Vol. 90. P. 14 - 17.

11. Pass R.F. et al. Congenital cytomegalovirus infection following first trimester maternal infection: Symptoms at birth and outcome//J. Clin. Virol. 2006. Vol. 35, N 2. P. 216 - 220.

12. Townsend C.L. et al. Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom//Clin. Infect. Dis. 2013. Vol. 56, N 9. P. 1232 - 1239.

13. Maltezou PG, Kourlaba G, Kourkouni E, Luck S, D, Ville Y, Lilleri D, Dimopoulou D, Karalexi M P. V. Maternal type of CMV infection and sequelae in infants with congenital CMV: Systematic review and meta-analysis.//J Clin Virol. 2020. Vol. 129. P. 104518.

14. Fowler K.B., Boppana S.B. Congenital cytomegalovirus (CMV) infection and hearing deficit//J. Clin. Virol. 2006. Vol. 35, N 2. P. 226 - 231.

15. Puhakka L. et al. Primary versus non-primary maternal cytomegalovirus infection as a cause of symptomatic congenital infection-register-based study from Finland//Infect. Dis. (Auckl). Informa UK Limited, trading as Taylor 8 Francis Group, 2017. Vol. 49, N 6. P. 445 - 453.

16. Kenneson A C.M. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection//Rev Med Virol. 2007. Vol. 17, N 4. P. 253 - 276.

17. Mussi-Pinhata M.M. et al. Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population//Clin. Infect. Dis. 2009. Vol. 49, N 4. P. 522 - 528.

18. Mussi-Pinhata M.M. et al. Seroconversion for Cytomegalovirus Infection during Pregnancy and Fetal Infection in a Highly Seropositive Population: "the BraCHS Study"//J. Infect. Dis. 2018. Vol. 218, N 8. P. 1200 - 1204.

19. Козлова С.Н., Савельева Е.В. Распространенность герпесвирусных инфекций у детей дошкольного образовательного учреждения Prevalence of herpes virus infections in children from preschool//Уральский медицинский журнал. 2015. Vol. 4, N 127. P. 45 - 50.

20. Аистова Л.Г., Провоторов В.Я., Калуцкий П.В. Встречаемость вирусов герпетической группы у вич - инфицированных лиц//Научные ведомости Белгородского государственного университета. серия: медицина. фармация. 2015. Vol. 4, N 201. P. 57 - 60.

21. Баратова М.А., Баратова Д.А., Нурлыханов Е.Б. Иммуногенетические показатели и распространенность носительства вируса Эпштейн-Барр, цитомегаловируса у потенциальных доноров гемопоэтических стволовых клеток//Современные проблемы науки и образования. 2014. Vol. 5. P. 446.

22. Майлян Э.А., Майлян Д.Э., Частота регистрации маркеров цитомегаловирусной инфекции по данным иммуноферментного анализа у жителей донецкого региона//Медико-социальные проблемы семьи. 2013. Vol. 18, N 2. P. 123 - 127.

23. Алямовская Г.А., Кешищян Е.С., Адуева С.М. и др. Выявление прямых маркеров цитомегаловируса и противовирусных антител у детей раннего возраста//Вопросы вирусологии. 2005. Vol. 50, N 1. P. 14 - 18.

24. Яцык Г.В., Одинаева Н.Д., Беляева И.А.. Цитомегаловирусная инфекция//Практика педиатра. 2009. N 10. P. 5 - 12.

25. Cannon M.J., Hyde T.B., Schmid D.S. Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection//Rev. Med. Virol. 2011. Vol. 21, N 4. P. 240 - 255.

26. Hyde TB, Schmid DS C.M. Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV.//Rev Med Virol. 2010. Vol. 20, N 5. P. 311 - 326.

27. Leruez-Ville M, Magny JF, Couderc S et al. Risk factors for congenital CMV infection following primary and non-primary maternal infeciton//Clin Infect Dis. 2017. Vol. 65, N 13. P. 398 - 404.

28. Wang C. et al. Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection//Clin. Infect. Dis. 2011. Vol. 52, N 2. P. 11 - 13.

29. Ssentongo P. et al. Congenital Cytomegalovirus Infection Burden and Epidemiologic Risk Factors in Countries with Universal Screening: A Systematic Review and Meta-analysis//JAMA Netw. Open. 2021. Vol. 4, N 8. P. 1 - 17.

30. Manicklal S. et al. The "Silent" global burden of congenital cytomegalovirus//Clin. Microbiol. Rev. 2013. Vol. 26, N 1. P. 86 - 102.

31. Dollard SC, Grosse SD R.D.. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection//Rev Med Virol. 2007. Vol. 17, N 5. P. 355 - 363.

32. Lin C. et al. Diagnosis and medical care for congenital cytomegalovirus infection An observational study using claims data in Japan, 2010 to 2017//Med. (United States). 2020. Vol. 99, N 10.

33. Mussi-Pinhata M.M., Yamamoto A.Y. Natural history of congenital cytomegalovirus infection in highly seropositive populations//J. Infect. Dis. 2021. Vol. 221, N Suppl 1. P. S15 - S22.

34. Korndewal M.J. et al. Long-term impairment attributable to congenital cytomegalovirus infection: a retrospective cohort study//Dev. Med. Child Neurol. 2017. Vol. 59, N 12. P. 1261 - 1268.

35. Александрова Е.П., Шахгильдян В.И. Анализ заболеваемости цитомегаловирусной инфекции в Российской Федерации за период 2008 - 2018 гг//Инфекционные болезни в современном мире: эпидемиология, диагностика, лечение и профилактика: Сборник трудов XII Ежегодного Всероссийского интернет-конгресса по инфекционным болезням с международным участием/ed. Под ред. В.И. Покровского. Москва: Общество с ограниченной ответственностью "Медицинское Маркетинговое Агентство," 2020. P. 9 - 10.

36. Шахгильдян В.И. Врожденная цитомегаловирусная инфекция: актуальные вопросы, возможные ответы//Неонатология: новости, мнения, обучение. 2020. Vol. 8, N 4. P. 61 - 72.

37. Кистенева Л.Б., Сухоруков В.С., Царегородцев А.Д. [и др.]. Персистирующие герпесвирусные инфекции у детей. Москва: Медицинское информационное агентство, 2021. 280 p.

38. Шахгильдян В.И., Александрова Е.П., Козырина Н.В., Шипулина О.Ю., Додонова Э.А., Шахгильдян Н.В.. Цитомегаловирусная инфекция у беременных и новорожденных: эпидемиологический анализ, новые подходы к диагностике и лечению//Акушерство и гинекология новости, мнения, обучение. 2020. Vol. 8, N 2. P. 80 - 94.

39. Rawlinson W.D. et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy//Lancet Infect. Dis. 2017. Vol. 17, N 6. P. e177-e188.

40. Volpe J.J. Neurology of the newborn. 5th editio. Saunders Elsevier, 2008. 1094 p.

41. Buonsenso D, Serranti D, Gargiullo L, Ceccarelli M, Ranno O. et al. Congenital cytomegalovirus infection: current strategies and future perspectives//Eur Rev Med Pharmacol Sci. 2012. Vol. 16, N 7. P. 919 - 935.

42. Hayakawa J, Kawakami Y, Takeda S, Ozawa H, Fukazawa R, Takase M, Fukunaga Y. A. A neonate with reduced cytomegalovirus DNA copy number and marked improvement of hearing in the treatment of congenital cytomegalovirus infection.//J Nippon Med Sch. 2012. Vol. 79, N 6. P. 471 - 477.

43. Nishida K. et al. Neurological outcomes in symptomatic congenital cytomegalovirus-infected infants after introduction of newborn urine screening and antiviral treatment//Brain Dev. The Japanese Society of Child Neurology, 2016. Vol. 38, N 2. P. 209 - 216.

44. Halwachs-Baumann G. et al. Human cytomegalovirus load in various body fluids of congenitally infected newborns//J. Clin. Virol. 2002. Vol. 25, N SUPPL. 3. P. 81 - 87.

45. Diogo M.C. et al. The MRI spectrum of congenital cytomegalovirus infection//Prenat. Diagn. 2020. Vol. 40, N 1. P. 110 - 124.

46. Kylat R.I., Kelly E.N., Ford-Jones E.L. Clinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus (SCCMV) infection//Eur. J. Pediatr. 2006. Vol. 165, N 11. P. 773 - 778.

47. Inagaki K. et al. Risk Factors, Geographic Distribution, and Healthcare Burden of Symptomatic Congenital Cytomegalovirus Infection in the United States: Analysis of a Nationally Representative Database, 2000 - 2012//J. Pediatr. Elsevier Inc., 2018. Vol. 199. P. 118 - 123. e1.

48. Luck S.E. et al. Congenital cytomegalovirus a European expert consensus statement on diagnosis and management//Pediatr. Infect. Dis. J. 2017. Vol. 36, N 12. P. 1205 - 1213.

49. Duval M., Park A.H. Congenital cytomegalovirus: What the otolaryngologist should know//Curr. Opin. Otolaryngol. Head Neck Surg. 2014. Vol. 22, N 6. P. 495 - 500.

50. Bartlett A.W. et al. Hearing and neurodevelopmental outcomes for children with asymptomatic congenital cytomegalovirus infection: A systematic review//Rev. Med. Virol. 2017. Vol. 27, N 5. P. 1 - 10.

51. Alarcon A. et al. Clinical, biochemical, and neuroimaging findings predict long-term neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection//J. Pediatr. 2013. Vol. 163, N 3.

52. Bernard S. et al. Vestibular disorders in children with congenital cytomegalovirus infection//Pediatrics. 2015. Vol. 136, N 4. P. e887-e895.

53. Dreher A.M. et al. Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection//J. Pediatr. Elsevier Ltd, 2014. Vol. 164, N 4. P. 855 - 859.

54. Bilavsky E. et al. Hearing outcome of infants with Congenital cytomegalovirus and hearing impairment//Arch. Dis. Child. 2016. Vol. 101, N 5. P. 433 - 438.

55. Coats D.K. et al. Ophthalmologic Findings in Children With Congenital Cytomegalovirus Infection//J AAPOS. 2000. Vol. 4, N 2. P. 110 - 116.

56. Boppana S.B., Ross S.A., Fowler K.B. Congenital cytomegalovirus infection: clinical outcome.//Clin. Infect. Dis. 2013. Vol. 57 Suppl 4, N Suppl 4. P. 178 - 181.

57. Liu P.-H. et al. Congenital cytomegalovirus infection and the risk of hearing loss in childhood//Medicine (Baltimore). 2021. Vol. 100, N 36. P. e27057.

58. Noyola D.E. et al. Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection//J. Pediatr. 2001. Vol. 138, N 3. P. 325 - 331.

59. Goderis J. et al. Hearing loss and congenital CMV infection: A systematic review//Pediatrics. 2014. Vol. 134, N 5. P. 972 - 982.

60. Hazen M., Cushing S.L. Implications of Concurrent Vestibular Dysfunction in Pediatric Hearing Loss//Curr. Otorhinolaryngol. Rep. Current Otorhinolaryngology Reports, 2020. Vol. 8, N 3. P. 267 - 275.

61. Pinninti S. et al. Vestibular, gaze, and balance disorders in asymptomatic congenital cytomegalovirus infection//Pediatrics. 2021. Vol. 147, N 2. P. e20193945.

62. Marsico C., Kimberlin D.W. Congenital Cytomegalovirus infection: Advances and challenges in diagnosis, prevention and treatment//Ital. J. Pediatr. Italian Journal of Pediatrics, 2017. Vol. 43, N 1. P. 1 - 8.

63. Luck S.E. et al. Compartmentalized dynamics of cytomegalovirus replication in treated congenital infection//J. Clin. Virol. Elsevier B.V., 2016. Vol. 82. P. 152 - 158.

64. Boppana SB, Ross SA, Shimamura M, Palmer AL, Ahmed A, Michaels MG, PJ, Bernstein DI, Tolan RW Jr, Novak Z, Chowdhury N, Britt WJ F.K. Saliva Polymerase-Chain-Reaction Assay for Cytomegalovirus Screening in Newborns//N Engl J Med. 2011. Vol. 364, N 22. P. 2111 - 2118.

65. Ross S.A. et al. Detection of Congenital Cytomegalovirus Infection by Real-Time Polymerase Chain Reaction Analysis of Saliva or Urine Specimens//J Infect Dis. 2014. Vol. 210, N 9. P. 1415 - 1418.

66. De Carvalho Cardoso E.S. et al. The use of saliva as a practical and feasible alternative to urine in large-scale screening for congenital cytomegalovirus infection increases inclusion and detection rates//Rev. Soc. Bras. Med. Trop. 2015. Vol. 48, N 2. P. 206 - 207.

67. De Vries J.J.C. et al. Real-time PCR versus viral culture on urine as a gold standard in the diagnosis of congenital cytomegalovirus infection//J. Clin. Virol. Elsevier B.V., 2012. Vol. 53, N 2. P. 167 - 170.

68. Eventov-friedman S. et al. Saliva Real-Time Polymerase Chain Reaction for Targeted Screening of Congenital Cytomegalovirus Infection//J Infect Dis. 2019. Vol. 220, N 11. P. 1790 - 1796.

69. Huang Y. et al. Comparison of detection strategies for screening and confirming congenital cytomegalovirus infection in newborns in a highly seroprevalent population: a mother-child cohort study//Lancet Reg. Heal. - West. Pacific. Elsevier Ltd, 2021. Vol. 12. P. 100182.

70. Atkins J.T. et al. Polymerase chain reaction to detect cytomegalovirus dna in the cerebrospinal fluid of neonates with congenital infection//J. Infect. Dis. 1994. Vol. 169, N 6. P. 1334 - 1337.

71. Ouellette C. et al. Detection of Cytomegalovirus (CMV) in Cerebrospinal Fluid of Infants with Congenital CMV Infection: Is It Worth Doing the Lumbar Puncture?//Open Forum Infect. Dis. 2014. Vol. 1, N suppl_1. P. 292.

72. Czech-Kowalska J. et al. The Limitations of Cytomegalovirus DNA Detection in Cerebrospinal Fluid of Newborn Infants With Congenital CMV Infection: A Tertiary Care Neonatal Center Experience//Pediatr. Infect. Dis. J. 2021. Vol. 40, N 9. P. 838 - 845.

73. Goycochea-Valdivia W.A. et al. Cytomegalovirus DNA Detection by Polymerase Chain Reaction in Cerebrospinal Fluid of Infants with Congenital Infection: Associations with Clinical Evaluation at Birth and Implications for Follow-up//Clin. Infect. Dis. 2017. Vol. 64, N 10. P. 1335 - 1342.

74. Bilavsky E. et al. Positive IgM in Congenital CMV Infection//Clin. Pediatr. (Phila). 2017. Vol. 56, N 4. P. 371 - 375.

75. Revello M.G. et al. Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns//J. Clin. Virol. 1999. Vol. 14, N 1. P. 57 - 66.

76. Ohyama S. et al. Diagnostic value of cytomegalovirus IgM antibodies at birth in PCR-confirmed congenital cytomegalovirus infection//Int. J. Mol. Sci. 2019. Vol. 20, N 13. P. 1 - 6.

77. Coll O. et al. Guidelines on CMV congenital infection//J. Perinat. Med. 2009. Vol. 37, N 5. P. 433 - 445.

78. Павлова М.В. et al. Цитомегаловирусная инфекция у недоношенных новорожденных детей: количественные методы лабораторного анализа//Журнал научных статей. Здоровье и образование в XXI веке. 2007. Vol. 1, N 9. P. 70 - 71.

79. Суслова М.А. Характеристика состояния специфического иммунитета к цитомегаловирусу в диаде "Мать - новорожденный ребенок"//Медицинский альманах. 2011. Vol. 5, N 18. P. 257 - 259.

80. T, Ljubin-Sternak S, G, Sviben M, G.. The role of IgG avidity in diagnosis of cytomegalovirus infection in newborns and infants.//Coll Antropol. 2012. Vol. 36, N 1. P. 297 - 300.

81. Benoist G. et al. Management of pregnancies with confirmed cytomegalovirus fetal infection//Fetal Diagn. Ther. 2013. Vol. 33, N 4. P. 203 - 214.

82. Simonazzi G. et al. Perinatal Outcomes of Non-Primary Maternal Cytomegalovirus Infection: A 15-Year Experience//Fetal Diagn. Ther. 2018. Vol. 43, N 2. P. 138 - 142.

83. Nigro G. Maternal-fetal cytomegalovirus infection: From diagnosis to therapy//J. Matern. Neonatal Med. 2009. Vol. 22, N 2. P. 169 - 174.

84. Tanimura K., Yamada H. Maternal and neonatal screening methods for congenital cytomegalovirus infection//J Obs. Gynaecol Res. 2019. Vol. 45, N 3. P. 514 - 521.

85. Benoist G. et al. The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus//BJOG An Int. J. Obstet. Gynaecol. 2008. Vol. 115, N 7. P. 823 - 829.

86. Guerra B. et al. Ultrasound prediction of symptomatic congenital cytomegalovirus infection//Am. J. Obstet. Gynecol. 2008. Vol. 198, N 4. P. 380. e1 - 380. e7.

87. Leyder M. et al. Primary maternal cytomegalovirus infections: accuracy of fetal ultrasound for predicting sequelae in offspring//Am. J. Obstet. Gynecol. Elsevier Ltd, 2016. Vol. 215, N 5. P. 638. e1 - 638. e8.

88. Imafuku H. et al. Clinical and ultrasound features associated with congenital cytomegalovirus infection as potential predictors for targeted newborn screening in high-risk pregnancies//Sci. Rep. Nature Publishing Group UK, 2020. Vol. 10, N 1. P. 1 - 8.

89. Lorenzoni F. et al. Neonatal screening for congenital cytomegalovirus infection in preterm and small for gestational age infants//J. Matern. Neonatal Med. 2014. Vol. 27, N 15. P. 1589 - 1593.

90. Turner K.M. et al. Incidence and impact of CMV infection in very low birth weight infants//Pediatrics. 2014. Vol. 133, N 3.

91. Luck S., Sharland M. Postnatal cytomegalovirus: Innocent bystander or hidden problem?//Arch. Dis. Child. Fetal Neonatal Ed. 2009. Vol. 94, N 1.

92. Mukhopadhyay S. et al. Symptomatic Postnatal Cytomegalovirus Testing among Very Low-Birth-Weight Infants: Indications and Outcomes//Am. J. Perinatol. 2016. Vol. 33, N 9. P. 894 - 902.

93. Tsuge M. et al. Prospective Cohort Study of Congenital Cytomegalovirus Infection during Pregnancy with Fetal Growth Restriction: Serologic Analysis and Placental Pathology.//J. Pediatr. Elsevier Inc., 2019. N 206. P. 42 - 48.

94. Liu P.H. et al. Congenital cytomegalovirus infection and the risk of hearing loss in childhood: A PRISMA-compliant meta-analysis//Medicine (Baltimore). 2021. Vol. 100, N 36. P. e27057.

95. Boppana SB, Pass RF, Britt WJ, Stagno S A.C. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality.//Pediatr Infect Dis J. 1992. Vol. 11, N 2. P. 93 - 99.

96. D'Amico A. et al. Outcome of fetal echogenic bowel: A systematic review and meta-analysis//Prenat. Diagn. 2021. Vol. 41, N 4. P. 391 - 399.

97. Kyriakopoulou A. et al. Antenatal imaging and clinical outcome in congenital CMV infection: A field-wide systematic review and meta-analysis//J. Infect. Elsevier Ltd, 2020. Vol. 80, N 4. P. 407 - 418.

98. Exler S. et al. Primary cytomegalovirus (CMV) infection in pregnancy: Diagnostic value of CMV PCR in saliva compared to urine at birth//J. Clin. Virol. Elsevier, 2019. Vol. 117, N February. P. 33 - 36.

99. Marsico C. et al. Blood Viral Load in Symptomatic Congenital Cytomegalovirus Infection//J. Infect. Dis. 2019. Vol. 219, N 9. P. 1398 - 1406.

100. Smiljkovic M. et al. Blood viral load in the diagnostic workup of congenital cytomegalovirus infection//J. Clin. Virol. Elsevier, 2020. Vol. 122, N September 2019. P. 104231.

101. Hu H., Peng Q. Clinical Features, Treatment Courses, and Distribution of Cytomegalovirus Genotypes among Thrombocytopenia Patients Aged Younger than 12 Months//Am J Perinatol. 2020.

102. Ronchi A. et al. Evaluation of clinically asymptomatic high risk infants with congenital cytomegalovirus infection//J. Perinatol. Springer US, 2019.

103. Kimberlin D.W. et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial.//J. Pediatr. 2003. Vol. 143, N 1. P. 16 - 25.

104. Kimberlin D.W. et al. Valganciclovir for symptomatic congenital cytomegalovirus disease//N. Engl. J. Med. 2015. Vol. 372, N 10. P. 933 - 943.

105. Aslam M, Anderson JL, Guglietti D C.D. CMV-Induced Neonatal Thrombocytopenia: A Case Report and Review of the Literature//Am J Perinatol. 2007. Vol. 24, N 7. P. 429 - 434.

106. M. et al. Renal involvement in congenital cytomegalovirus infection: A systematic review//Microorganisms. 2021. Vol. 9, N 6. P. 1 - 22.

107. Beswick R., Driscoll C., Kei J. Monitoring for Postnatal Hearing Loss Using Risk Factors: A Systematic Literature Review//Ear Hear. 2012. Vol. 33, N 6. P. 745 - 756.

108. Fowler K.B. et al. Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed?//J Pediatr. 1999. Vol. 135, N 1. P. 60 - 64.

109. Capretti MG, Lanari M, Tani G, Ancora G, Sciutti R, Marsico C, Lazzarotto T, Gabrielli L, Guerra B, Corvaglia L F.G. Role of cerebral ultrasound and magnetic resonance imaging in newborns with congenital cytomegalovirus infection//Brain Dev. The Japanese Society of Child Neurology, 2014. Vol. 36, N 3. P. 203 - 211.

110. Vries L.S. De et al. The Spectrum of Cranial Ultrasound and Magnetic Resonance Imaging Abnormalities in Congenital Cytomegalovirus Infection//Neuropediatrics. 2004. Vol. 35, N 2. P. 113 - 119.

111. Manara R, Balao L, Baracchini C, Drigo P, D'Elia R, Ruga EM. Brain magnetic resonance findings in symptomatic congenital cytomegalovirus infection//Pediatr Radiol. 2011. Vol. 41, N 8. P. 962 - 970.

112. Escobar Castellanos M. et al. Association between neuroimaging findings and neurological sequelae in patients with congenital cytomegalovirus infection//Neurol. (English Ed. 2019. N 8. P. S0213 - 4853.

113. Zhao D. et al. Effects of cytomegalovirus infection on the differential diagnosis between biliary atresia and intrahepatic cholestasis in a Chinese large cohort study//Ann. Hepatol. Fundación Clínica Médica Sur, A.C., 2021. Vol. 23. P. 100286.

114. De Oliveira N.L.G. et al. Infection by cytomegalovirus in patients with neonatal cholestasis//Arq. Gastroenterol. 2002. Vol. 39, N 2. P. 132 - 136.

115. Lee-Yoshimoto M. et al. Congenital cytomegalovirus pneumonitis and treatment response evaluation using viral load during ganciclovir therapy: A case report//Jpn. J. Infect. Dis. 2018. Vol. 71, N 4. P. 309 - 311.

116. Reiterer F. et al. Cytomegalovirus associated neonatal pneumonia and Wilson-Mikity syndrome: A causal relationship?//Eur. Respir. J. 1999. Vol. 13, N 2. P. 460 - 462.

117. Bradshaw J.H., Moore P.P.C. Perinatal cytomegalovirus infection associated with lung cysts//J. Paediatr. Child Health. 2003. Vol. 39, N 7. P. 563 - 566.

118. Gianolio L. et al. Ventricular septal defect and aortic hypoplasia in congenital cytomegalovirus infection: occasional finding or underdetected correlation?//J. Matern. Neonatal Med. Taylor & Francis, 2021. Vol. 0, N 0. P. 1 - 3.

119. Reyes C, Pereira S, Warden MJ S.J. Cytomegalovirus enteritis in a premature infant.//J Pediatr Surg. 1997. Vol. 32, N 11. P. 1545 - 1547.

120. Porta A. et al. Neonatal gastrointestinal involvement and congenital cytomegalovirus//Pediatr. Medica e Chir. 2016. Vol. 38, N 3. P. 75 - 79.

121. Erice A. Resistance of Human Cytomegalovirus to Antiviral Drugs//Clin Microbiol Rev. 1999. Vol. 12, N 2. P. 286 - 297.

122. Choi K.Y. et al. Emergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection//J. Clin. Virol. Elsevier B.V., 2013. Vol. 57, N 4. P. 356 - 360.

123. Куюмчъян С.Х., Васильев В.В., Иванова М.В., Сидоренко С.В., Мурина Е.А., Кветная А.С., Васильева Ю.П., Ушакова Г.М., Жанарстанова Г.А.. Реактивация латентной цитомегаловирусной инфекции как причина врожденного заболевания (клинический случай)//Российский семейный врач. 2013. Vol. 17, N 1. P. 36 - 39.

124. Weng Y.H. et al. Clinical experience with ganciclovir and anti-cytomegalovirus immunoglobulin treatment for a severe case of congenital cytomegalovirus infection//Chang Gung Med. J. 2003. Vol. 26, N 2. P. 128 - 132.

125. Беляева И.А., Бомбардирова Е.П., Потехина Т.В., Гурская А.С., Цитомегаловирусная инфекция у детей первых месяцев жизни: варианты течения, современные подходы к терапии (клинические случаи)//Педиатрическая фармакология. 2018. Vol. 15, N 2. P. 168 - 174.

126. Мангушева Я.Р., Хаертынова И.М. М.Л.И. Цитомегаловирусная инфекция у детей//Практическая медицина. 2014. Vol. 7, N 83.

127. Божбанбаева Н.С., Адилбекова И.М., Алтынбаева Г.Б. [и др.]. Состояние соматического здоровья детей первого года жизни с цитомегаловирусной инфекцией//Медицинский журнал Западного Казахстана. 2015. Vol. 2, N 46. P. 29 - 32.

128. Вайнштейн Н.П. et al. Клинический случай цитомегаловирусной инфекции у недоношенного ребенка//Неонатология: новости, мнения, обучение. 2017. Vol. 2, N 16. P. 99 - 106.

129. Баранова И.П. Структура поражений нервной системы у детей с врожденной цитомегаловирусной инфекцией и их динамика на фоне противовирусной терапии//Unity Sci. Int. Sci. Period. Journal. 2017. N 2. P. 111 - 113.

130. Рогозина Н.В., Васильев В.В., Гринева А.А. [и др.]. Анте и постнатальная диагностика и комплексное лечение врожденной цитомегаловирусной инфекции//Российский Вестник Перинатологии И Педиатрии. 2019. Vol. 64, N 4. P. 320.

131. Балыкова Л.А., Верещагина В.С., Ледяйкина Л.В. [и др.]. Клинический случай: врожденная цитомегаловирусная инфекция//Российский педиатрический журнал. 2020. Vol. 1, N 3. P. 37 - 41.

132. D, Golemac M, Pugel EP, Tomac J, Cicin-Sain L, Slavuljica I, Bradford R, Misch S, Winkler TH, Mach M, Britt WJ J.S. Passive Immunization Reduces Murine Cytomegalovirus-Induced Brain Pathology in Newborn Mice //J Virol. 2008. Vol. 82, N 24. P. 12172 - 12180.

133. Del Rosal T. et al. Treatment of symptomatic congenital cytomegalovirus infection beyond the neonatal period//J. Clin. Virol. Elsevier B.V., 2012. Vol. 55, N 1. P. 72 - 74.

134. Turriziani Colonna A. et al. Long-Term Clinical, Audiological, Visual, Neurocognitive and Behavioral Outcome in Children With Symptomatic and Asymptomatic Congenital Cytomegalovirus Infection Treated With Valganciclovir//Front. Med. 2020. Vol. 7, N July.

135. Ohyama S. et al. Efficacy of valganciclovir treatment depends on the severity of hearing dysfunction in symptomatic infants with congenital cytomegalovirus infection//Int. J. Mol. Sci. 2019. Vol. 20, N 6. P. 2 - 10.

136. Amir J., Attias J., Pardo J. Treatment of late-onset hearing loss in infants with congenital cytomegalovirus infection//Clin. Pediatr. (Phila). 2014. Vol. 53, N 5. P. 444 - 448.

137. Torrecillas V. et al. Should You Follow the Better-Hearing Ear for Congenital Cytomegalovirus Infection and Isolated Sensorineural Hearing Loss?//Otolaryngol. - Head Neck Surg. (United States). 2020. Vol. 162, N 1. P. 114 - 120.

138. Natale F. et al. Isolated auditory neuropathy at birth in congenital cytomegalovirus infection//Ital. J. Pediatr. Italian Journal of Pediatrics, 2020. Vol. 46, N 1. P. 3 - 9.

139. Lanzieri T.M. et al. Hearing loss in children with asymptomatic congenital cytomegalovirus infection//Pediatrics. 2017. Vol. 139, N 3.

140. Pasternak Y. et al. Valganciclovir Is Beneficial in Children with Congenital Cytomegalovirus and Isolated Hearing Loss//J. Pediatr. Elsevier Inc., 2018. Vol. 199. P. 166 - 170.

141. https://clinicaltrials.gov/ct2/show/NCT03107871?term=03107871&draw=2&rank=1 [Electronic resource].

142. https://clinicaltrials.gov/ct2/show/NCT01649869?term=01649869&draw=2&rank=1 [Electronic resource].

143. https://clinicaltrials.gov/ct2/show/NCT02005822?term=02005822&draw=2&rank=1 [Electronic resource].

144. https://clinicaltrials.gov/ct2/show/NCT03301415?term=03301415&draw=2&rank=1 [Electronic resource].

145. Вайнштейн Н.П. et al. Роль цитомегаловирусной инфекции в поражении желудочно-кишечного тракта у новорожденных и детей раннего возраста//Неонатология: новости, мнения, обучение. 2018. Vol. 6, N 4. P. 70 - 85.

146. Петрова Г.В., Шахгильдян В.И., Чистозвонова Е.А. Опыт применения противовирусной терапии врожденной генерализованной цитомегаловирусной инфекции//Детские инфекции. 2017. Vol. 15, N 2. P. 61 - 68.

147. Section on Breastfeeding. Breastfeeding and the Use of Human Milk//Pediatrics. 2012. Vol. 129, N 3. P. e827 LP - e841.

148. Hughes BL G.-B.C. Society for Maternal-Fetal Medicine (SMFM). Diagnosis and antenatal management of congenital cytomegalovirus infection//Am J Obs. Gynecol. 2016. Vol. 214, N 6. P. B5 - B11.

149. Barber V, Calvert A, Vandrevala T, Star C, Khalil A, Griffiths P, Heath PT J.C. Prevention of Acquisition of Cytomegalovirus Infection in Pregnancy Through Hygiene-based Behavioral Interventions: A Systematic Review and Gap Analysis.//Pediatr Infect Dis J. 2020. Vol. 39, N 10. P. 949 - 954.

150. Harvey J., Dennis C. Hygiene interventions for prevention of cytomegalovirus infection among childbearing women: systematic review//J Adv Nurs. 2008. Vol. 63, N 5. P. 440 - 450.

151. Billette de Villemeur A, Tattevin P S.L. Hygiene promotion might be better than serological screening to deal with Cytomegalovirus infection during pregnancy: a methodological appraisal and decision analysis//BMC Infect Dis. BMC Infectious Diseases, 2020. Vol. 20, N 1. P. 418.

152. D, Galindo Izquierdo A, Del Rosal T, Baquero-Artigao F, Izquierdo N, Soriano-Ramos M, Rojo Conejo P, MI, A, N, V, Ramos-Amador JT D. la C.M. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid.//J Matern Fetal Neonatal Med. 2017. Vol. 32, N 4. P. 617 - 625.

153. Chiaie LD, Neuberger P, Vochem M, Lihs A, Karck U E.M. No evidence of obstetrical adverse events after hyperimmune globulin application for primary cytomegalovirus infection in pregnancy: experience from a single centre//Arch. Gynecol. Obstet. Springer Berlin Heidelberg, 2018. Vol. 297, N 6. P. 1389 - 1395.

154. Germer M, Herbener P S.J. Functional Properties of Human Cytomegalovirus Hyperimmunoglobulin and Standard Immunoglobulin Preparations//Ann Transplant. 2016. Vol. 6, N 21. P. 558 - 564.

155. Kagan KO, Enders M, Schampera MS, Baeumel E, Hoopmann M, Geipel A, Berg C, Goelz R, De Catte L, Wallwiener D, Brucker S, Adler SP, Jahn G H.K. Prevention of maternal - fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration//Ultrasound Obs. Gynecol. 2019. Vol. 53, N 3. P. 383 - 389.

156. Nigro G. Hyperimmune globulin in pregnancy for the prevention of congenital cytomegalovirus disease//Expert Rev. Anti. Infect. Ther. Taylor & Francis, 2017. Vol. 15, N 11. P. 977 - 986.

157. Revello MG, Lazzarotto T, Guerra B, Spinillo A, Ferrazzi E, Kustermann A, Guaschino S, Vergani P, Todros T, Frusca T, Arossa A, Furione M, Rognoni V, Rizzo N, Gabrielli L, Klersy C G.G. A Randomized Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus//N Engl J Med. 2014. Vol. 370, N 14. P. 1316 - 1326.

158. Hughes B.L. et al. A Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus Infection//N. Engl. J. Med. 2021. Vol. 385, N 5. P. 436 - 444.

159. Shahar-Nissan K. et al. Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial//Lancet. Elsevier Ltd, 2020. Vol. 396, N 10253. P. 779 - 785.

160. D'Antonio F, Marinceu D, Prasad S, Khalil A.D'Antonio F, Marinceu D, Prasad S K.A. Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis.//Ultrasound Obs. Gynecol. 2022. Vol. 9.

161. Jin H.D. et al. Long-term Visual and Ocular Sequelae in Patients with Congenital Cytomegalovirus Infection//Pediatr. Infect. Dis. J. 2017. Vol. 36, N 9. P. 877 - 882.